The Business Angel Summit, organized by GIZ, is a key event that fosters innovation and investment in the startup ecosystem of Bosnia and Herzegovina. Building on last year’s success, which underscored the summit’s significant role in connecting entrepreneurs with investors, this year’s edition was even more competitive and dynamic.
The team behind TrueAId, our AI software specialized in assessing neurological risks in fetuses, proudly participated in GIZ’s two-month training program designed to enhance our business strategy and presentation skills.
In a competitive semifinal featuring 20 of the most promising startups from the Western Balkans, TrueAId secured a place in the top 10, thus earning the opportunity to showcase our innovations at the Business Angel Summit (BAS). This exciting achievement has brought us closer to critical investments and positioned us to introduce our groundbreaking technology to the European healthcare market. Our appearance at the BAS could prove to be a pivotal moment, with the potential to attract significant funding and expertise from the industry, accelerating our mission.
By bridging research, industry, and entrepreneurship, the Verlab Institute provides an environment where innovative ideas like TrueAId can evolve from concept to market-ready solutions. The Verlab Institute not only advances medical and technological innovations but also plays a crucial role in the economic development of the region. Our commitment to transforming research into successful entrepreneurial ventures shapes the future of healthcare and technology in Bosnia and beyond.
